about
sameAs
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial.Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children.Affordable, abbreviated roche monitor assay for quantification of human immunodeficiency virus type 1 RNA in plasma.Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.Antibody maturation and viral diversification in HIV-infected women.Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trialMethods for assessing quality of provider performance in developing countries.Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi.Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi.Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.Trends in birth weight and gestational age for infants born to HIV-infected, antiretroviral treatment-naive women in MalawiStavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.Evaluation of postpartum HIV superinfection and mother-to-child transmission.Child mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009.The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newbornsMaternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.Distribution of haematological and chemical pathology values among infants in Malawi and Uganda.Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.The impact of breastfeeding on the health of HIV-positive mothers and their children in sub-Saharan Africa.Training for health services and systems research in Sub-Saharan Africa--a case study at four East and Southern African universities.Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life.Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035).Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants.Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057.Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi.Malaria and human immunodeficiency virus infection among male employees of a sugar estate in Malawi.Diagnosis of female genital schistosomiasis by indirect disease markers: determination of eosinophil cationic protein, neopterin and IgA in vaginal fluid and swab eluates.Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report.Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi.Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naive Malawian women.Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi.Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.
P50
Q30569674-DE4BB05F-A840-4320-B3B9-B01539CFF549Q33275194-053F549B-DF7F-429F-98B1-9447E2B9E14DQ33648264-1623F861-810C-4B18-AA03-070201086914Q33872160-39B775E3-926F-4CA6-9AB9-169A9F4D0DE6Q34041955-EE21D221-E768-4BA4-88B1-71DEDEC7592FQ34549627-71D5C857-9256-4453-B56F-DA9A52CDAD63Q34608508-6A5F83ED-A5F0-43F6-9C2D-C88BA03793BCQ34711999-FF09F25A-9B17-419E-80B9-5D676A57E3FDQ34756810-762099A6-EBBD-46FB-B586-34A399331671Q35043592-C507305B-B776-4C1A-B226-AA51D157903AQ35062018-46B48C6E-748E-4922-B624-9657CA670BB4Q35452458-BB185218-F61A-4D1C-BC03-0C77ED494C51Q35682303-BA64A89C-BBCB-4112-9A66-B848DFF12FDFQ35780244-DAEE60E3-21FA-4CA1-9AFF-980C55401D50Q35790256-3FF983C2-5BAA-4D81-9A45-63B7A5635758Q35897529-57915657-C471-4A4C-80B1-75C81F6F9610Q36113222-07D3D121-BDB1-4626-B81E-0909E94BD2E4Q36174430-01DC58CD-A216-4CA1-B728-62E68A4D7244Q36279151-4716CFC9-03AF-44B7-A6D5-C67637A89BDAQ36433157-6305BC19-E8AB-41E7-98CB-1AB1F634E74FQ36581681-C2E3F442-4884-4F02-83AB-D0073C0139E4Q36606419-0D38BEFC-8836-4FF3-B5EA-C90142725FE6Q37009811-FD529ED2-CD2F-4D69-AD8A-8DFA9F655D08Q37063553-6425ADC1-248C-4326-B07C-5518503FD94DQ37425296-B62FAE6E-D317-4884-8C6E-008B27226370Q37551251-2A34C552-326D-4D45-9F2D-1641EFDAB701Q37705259-02C156C6-7F35-4F8B-86B8-30775FFA2428Q38292257-BF7440BB-DCEE-491A-8C99-D68D216C4D07Q38801873-132A141C-76C7-46DD-80E7-CC4DC1BB6F7FQ38879379-16C2BBD8-B2B8-4990-BC5C-D89DF333B869Q38880827-16B2566F-0678-4CDA-A5AF-A0AB65C5D057Q39094740-3B619C05-45E8-4F22-96A9-A274B3879057Q39312681-4E841D75-9C7C-4A30-BE28-9A24163EB72FQ39361514-87880DB7-C811-453B-8EDB-B696A97B064BQ39397558-8EFD1847-2D18-4257-B972-70A6B02297D3Q39460463-9A34C3F8-A19F-49BA-AD9C-BF8F062F1EB2Q40284630-8C7F48E7-52F4-4D13-92FA-C0629108F08AQ43257966-029A28F7-A89E-4387-AE84-BD7B425E12FBQ43260833-469408B6-0B55-4F6C-97FD-DB1A9BF79C0CQ43518589-4C3C305F-6FFE-40D0-BADE-D8A5324638BC
P50
description
hulumtues
@sq
onderzoeker uit Malawi
@nl
researcher
@en
հետազոտող
@hy
name
Newton Kumwenda
@ast
Newton Kumwenda
@en
Newton Kumwenda
@es
Newton Kumwenda
@nl
Newton Kumwenda
@sl
type
label
Newton Kumwenda
@ast
Newton Kumwenda
@en
Newton Kumwenda
@es
Newton Kumwenda
@nl
Newton Kumwenda
@sl
altLabel
Newton Isaac Kumwenda
@en
prefLabel
Newton Kumwenda
@ast
Newton Kumwenda
@en
Newton Kumwenda
@es
Newton Kumwenda
@nl
Newton Kumwenda
@sl
P106
P1153
7003723279
P21
P27
P31
P496
0000-0003-2622-4339
P569
2000-01-01T00:00:00Z